1473PPHASE 1B TRIAL OF ANTI-NOTCH 2/3 ANTIBODY OMP-59R5 IN...

1473PPHASE 1B TRIAL OF ANTI-NOTCH 2/3 ANTIBODY OMP-59R5 IN COMBINATION WITH ETOPOSIDE AND CISPLATIN (EP) IN PATIENTS (PTS) WITH UNTREATED EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (ED-SCLC): THE PINNACLE STUDY

Pietanza, M.C., Spira, A., Jotte, R., Gadgeel, S., Mita, A., Liu, S., Gluck, W.L., Kalemkerian, G.P., Chiang, A., Hart, L., Kapoun, A., Xu, L., Hill, D., Zhou, L., Dupont, J., Spigel, D.R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu355.11
Date:
September, 2014
File:
PDF, 66 KB
2014
Conversion to is in progress
Conversion to is failed